Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
The childhood vaccines that the CDC is dropping from the recommended scheduled have successfully beat back illness and death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback